Detalles de la búsqueda
1.
New Approaches to Investigate Drug-Induced Hypersensitivity.
Chem Res Toxicol;
30(1): 239-259, 2017 01 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-27806199
2.
No Evidence for Drug-Specific Activation of Circulating T Cells from Patients with HLA-DRB1*07:01-Restricted Lapatinib-Induced Liver Injury.
Chem Res Toxicol;
29(12): 2111-2113, 2016 12 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-27989141
3.
A comparison of Bayesian and frequentist approaches to incorporating external information for the prediction of prostate cancer risk.
Genet Epidemiol;
36(1): 71-83, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22890972
4.
A proposed modification to Hy's law and Edish criteria in oncology clinical trials using aggregated historical data.
Pharmacoepidemiol Drug Saf;
22(6): 571-8, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23300062
5.
Association of the hemochromatosis gene with pazopanib-induced transaminase elevation in renal cell carcinoma.
J Hepatol;
54(6): 1237-43, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21145803
6.
HLA-B*57:01 Confers Susceptibility to Pazopanib-Associated Liver Injury in Patients with Cancer.
Clin Cancer Res;
22(6): 1371-7, 2016 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26546620
7.
Rash in lapatinib-treated patients is not associated with human leukocyte antigen polymorphisms.
Pharmacogenomics;
16(11): 1227-9, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26265235
8.
Prospective validation of HLA-DRB1*07:01 allele carriage as a predictive risk factor for lapatinib-induced liver injury.
J Clin Oncol;
32(22): 2296-303, 2014 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24687830
9.
Genetic characterization to improve interpretation and clinical management of hepatotoxicity caused by tyrosine kinase inhibitors.
Pharmacogenomics;
14(5): 541-54, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23556451
10.
Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: findings from the REDUCE trial.
Eur Urol;
62(6): 953-61, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22652152
11.
HLA-DQA1*02:01 is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer.
J Clin Oncol;
29(6): 667-73, 2011 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-21245432
12.
Pazopanib efficacy in renal cell carcinoma: evidence for predictive genetic markers in angiogenesis-related and exposure-related genes.
J Clin Oncol;
29(18): 2557-64, 2011 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-21576632
13.
Pharmacogenetics and obesity: common gene variants influence weight loss response of the norepinephrine/dopamine transporter inhibitor GW320659 in obese subjects.
Pharmacogenet Genomics;
15(12): 883-9, 2005 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-16272960
Resultados
1 -
13
de 13
1
Próxima >
>>